Clinical Characteristics and Incidences of Benign and Malignant Insulinoma Using a National Inpatient Database in Japan
- PMID: 34343300
- DOI: 10.1210/clinem/dgab559
Clinical Characteristics and Incidences of Benign and Malignant Insulinoma Using a National Inpatient Database in Japan
Abstract
Context: Insulinoma is the most common pancreatic functional neuroendocrine neoplasm, yet little information on recent clinical practice in patients with insulinoma, especially malignant insulinoma, is available.
Objective: This work aims to clarify the characteristics and practice patterns in patients with insulinoma using a national inpatient database.
Methods: Using the Japanese Diagnosis Procedure Combination database, we retrospectively identified patients with insulinoma admitted between 2010 and 2018. We compared background characteristics and therapeutic interventions between patients with benign and malignant insulinoma. We also estimated the incidence of insulinoma using the number of patients with newly diagnosed insulinoma in 2012.
Results: We identified 844 patients with benign insulinoma and 102 patients with malignant insulinoma. Patients with malignant insulinoma were younger (median, 55.5 vs 66.0 years, P < .001) and less likely to be female (55.9% vs 65.3%, P = .061) than patients with benign insulinoma. Analysis of therapeutic interventions revealed that patients with malignant insulinoma more frequently received medications (71.6% vs 49.6%, P < .001) but less frequently underwent pancreatic surgery (57.8% vs 72.0%, P = .003). Older patients were a smaller proportion of those undergoing surgery and a larger proportion of those managed with medications without surgery (P < .001). The incidence of insulinoma was estimated to be 3.27 (95% CI, 2.93-3.61) individuals per million Japanese adult population per year.
Conclusion: The present study using a nationwide database had a larger sample size than previous studies and revealed definitive differences in patient characteristics and therapeutic patterns between benign and malignant insulinoma.
Keywords: clinical epidemiology; database study; insulinoma; medications; surgery.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma.J Am Coll Surg. 2022 Nov 1;235(5):756-763. doi: 10.1097/XCS.0000000000000307. Epub 2022 Oct 17. J Am Coll Surg. 2022. PMID: 35752874
-
Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor.World J Surg. 2020 Jul;44(7):2288-2294. doi: 10.1007/s00268-020-05445-x. World J Surg. 2020. PMID: 32128613 Free PMC article. Review.
-
Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors.Pancreatology. 2018 Apr;18(3):298-303. doi: 10.1016/j.pan.2018.01.009. Epub 2018 Feb 1. Pancreatology. 2018. PMID: 29452754
-
Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan.Endocr J. 2012;59(10):859-66. doi: 10.1507/endocrj.ej12-0173. Epub 2012 Jun 16. Endocr J. 2012. PMID: 22785103
-
Insulinoma in pregnancy.Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):9-18. doi: 10.1055/s-0029-1202272. Epub 2009 Apr 16. Exp Clin Endocrinol Diabetes. 2010. PMID: 19373751 Review.
Cited by
-
Approach to the Patient: Insulinoma.J Clin Endocrinol Metab. 2024 Mar 15;109(4):1109-1118. doi: 10.1210/clinem/dgad641. J Clin Endocrinol Metab. 2024. PMID: 37925662 Free PMC article.
-
ATP6AP2 is robustly expressed in pancreatic β cells and neuroendocrine tumors, and plays a role in maintaining cellular viability.Sci Rep. 2023 Jun 7;13(1):9260. doi: 10.1038/s41598-023-36265-3. Sci Rep. 2023. PMID: 37286698 Free PMC article.
-
The incidence of insulinoma in Western Sweden between 2002 and 2019.Ann Gastroenterol. 2022 Jul-Aug;35(4):434-440. doi: 10.20524/aog.2022.0707. Epub 2022 Mar 25. Ann Gastroenterol. 2022. PMID: 35784630 Free PMC article.
-
Unmet needs in current clinical practice for insulinoma: Lessons from nationwide studies in Japan.J Diabetes Investig. 2022 Mar;13(3):429-431. doi: 10.1111/jdi.13730. Epub 2021 Dec 15. J Diabetes Investig. 2022. PMID: 34863032 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical